A pilot studt--the relation between the time of the initial hormone therapy and the prevention of the puerperal breast engorgement
Lee, Y.S.
Hu Li Za Zhi Journal of Nursing 21(3): 7-8
1974
ISSN/ISBN: 0047-262X PMID: 4497886 Document Number: 71135
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356Spicer, D.; Pike, M.; Lobo, R.; Paganini-Hill, A.; Richardson, J.; Dworsky, R.; Weaver, F. 1990: Gonadotropin hormone releasing hormone agonists [GnRHA] and prevention of familial breast cancer Progress in Clinical and Biological Research 339: 193-199
Pannuti, F.; Rossi, A.P.; Di Marco, A.R.; Fruet, F.; Lelli, G.; Strocchi, E.; Rocchetta, G.; Piana, E.; Martoni, A. 1981: Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study Panminerva Medica 23(1): 25-28
Koshiishi, T.; Furusawa, Y.; Iseki, H.; Iwasaki, Y. 1971: A double blind study of the effects of Kimotab on engorgement of the breast Acta Obstetrica et Gynaecologica Japonica 18(4): 222-228
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Stierli, P.; Spichtig, S.; Aeberhard, P. 1992: Breast saving therapy of breast cancer: sensitivity of mammography in relation to primary tumor size Helvetica Chirurgica Acta 59(1): 247-252
Nezu, Y. 1985: Self massaging of the breast: practice of puerperal breast care (the Suwa Maternity Clinic method) Josanpu Zasshi 39(3): 216-232
Sato, T.; Nakagawa, T.; Kuwayama, T.; Oda, G.; Kuboto, K.; Machida, Y.; Kawachi, H.; Sugihara, K. 2010: Pilot study of radiofrequency ablation (RFA) therapy in patients with early breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2750-2752
Akhundov, S.N.; Toritsina, L.K.; Karina, I.M. 1985: Serum parathyroid hormone and calcitonin levels in bronchial asthma in relation to glucocorticoid therapy Klinicheskaia Meditsina 63(6): 71-74
Schneider, G. 1993: Adjuvant hormone therapy in breast carcinoma Deutsche Medizinische Wochenschrift 118(25): 961-962
Wehrlin, N. 1983: Therapeutics: hormone therapy for breast cancer Revue de l'Infirmiere 33(11): 35-38
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
Ersbøll, J. 2004: Breast cancer, mammography screening and hormone therapy Ugeskrift for Laeger 166(36): 3113-3114
Fiorica, J. 2001: Association between changes in hormone replacement therapy and breast density JAMA 285(14): 1839-1840
Köhler, A.; Noss, W.; Dobberstein, N.; Stoltmann, R.; Pohl, J. 1986: Hormone therapy of metastasizing breast cancer with tamoxifen Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(1): 6-9
Levgur, M. 2004: Hormone therapy for women after breast cancer: a review Journal of Reproductive Medicine 49(7): 510-526
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Gadducci, A.; Guerrieri, M.E.; Genazzani, A.R. 2012: Benign breast diseases, contraception and hormone replacement therapy Minerva Ginecologica 64(1): 67-74